Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127718951 | 12771895 | 1 | I | 20130101 | 20160915 | 20160922 | 20160922 | EXP | CA-HLSUS-2016-CA-000462 | HLS THERAPEUTICS | 18.48 | YR | A | M | Y | 0.00000 | 20160922 | MD | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127718951 | 12771895 | 1 | PS | CLOZARIL | CLOZAPINE | 1 | Oral | U | 0 | TABLET | |||||||||
127718951 | 12771895 | 2 | C | RISPERDAL | RISPERIDONE | 1 | 7 MG DAILY | 0 | 7 | MG | QD | ||||||||
127718951 | 12771895 | 3 | C | LITHIUM CARBONATE. | LITHIUM CARBONATE | 1 | 0 | 1500 | MG | QD |
Indications of drugs used
no results found |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127718951 | 12771895 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127718951 | 12771895 | Condition aggravated | |
127718951 | 12771895 | Hospitalisation | |
127718951 | 12771895 | Impaired work ability | |
127718951 | 12771895 | Off label use | |
127718951 | 12771895 | Schizoaffective disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127718951 | 12771895 | 1 | 20110525 | 0 |